First Trust Advisors’s Phibro Animal Health PAHC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-57,143
| Closed | -$958K | – | 2453 |
|
2024
Q2 | $958K | Sell |
57,143
-489
| -0.8% | -$8.2K | ﹤0.01% | 1962 |
|
2024
Q1 | $745K | Buy |
57,632
+1,743
| +3% | +$22.5K | ﹤0.01% | 2055 |
|
2023
Q4 | $647K | Buy |
55,889
+1,328
| +2% | +$15.4K | ﹤0.01% | 2083 |
|
2023
Q3 | $697K | Buy |
54,561
+9
| +0% | +$115 | ﹤0.01% | 2072 |
|
2023
Q2 | $747K | Buy |
54,552
+406
| +0.7% | +$5.56K | ﹤0.01% | 2044 |
|
2023
Q1 | $830K | Buy |
54,146
+4,128
| +8% | +$63.2K | ﹤0.01% | 2014 |
|
2022
Q4 | $671K | Sell |
50,018
-3,476
| -6% | -$46.6K | ﹤0.01% | 2095 |
|
2022
Q3 | $711K | Buy |
53,494
+23,147
| +76% | +$308K | ﹤0.01% | 2107 |
|
2022
Q2 | $581K | Sell |
30,347
-835
| -3% | -$16K | ﹤0.01% | 2155 |
|
2022
Q1 | $622K | Sell |
31,182
-1,810
| -5% | -$36.1K | ﹤0.01% | 2199 |
|
2021
Q4 | $674K | Buy |
32,992
+3,994
| +14% | +$81.6K | ﹤0.01% | 2200 |
|
2021
Q3 | $625K | Sell |
28,998
-22,825
| -44% | -$492K | ﹤0.01% | 2207 |
|
2021
Q2 | $1.5M | Sell |
51,823
-1,544
| -3% | -$44.6K | ﹤0.01% | 1920 |
|
2021
Q1 | $1.3M | Buy |
53,367
+4,277
| +9% | +$104K | ﹤0.01% | 1900 |
|
2020
Q4 | $953K | Sell |
49,090
-2,315
| -5% | -$44.9K | ﹤0.01% | 1911 |
|
2020
Q3 | $894K | Buy |
51,405
+10,672
| +26% | +$186K | ﹤0.01% | 1812 |
|
2020
Q2 | $1.07M | Buy |
40,733
+2,872
| +8% | +$75.4K | ﹤0.01% | 1708 |
|
2020
Q1 | $915K | Sell |
37,861
-7,386
| -16% | -$179K | ﹤0.01% | 1665 |
|
2019
Q4 | $1.12M | Sell |
45,247
-798
| -2% | -$19.8K | ﹤0.01% | 1838 |
|
2019
Q3 | $982K | Buy |
+46,045
| New | +$982K | ﹤0.01% | 1878 |
|
2018
Q3 | – | Sell |
-22,586
| Closed | -$1.04M | – | 2508 |
|
2018
Q2 | $1.04M | Buy |
22,586
+3,769
| +20% | +$174K | ﹤0.01% | 1923 |
|
2018
Q1 | $747K | Buy |
18,817
+1,246
| +7% | +$49.5K | ﹤0.01% | 1905 |
|
2017
Q4 | $589K | Buy |
17,571
+2,212
| +14% | +$74.1K | ﹤0.01% | 2042 |
|
2017
Q3 | $569K | Buy |
+15,359
| New | +$569K | ﹤0.01% | 2040 |
|